← Browse by Condition
Medical Condition

cannabis use

Total Trials
7
Recruiting Now
7
Trial Phases
Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for cannabis use sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cannabis use Clinical Trials

How many clinical trials are currently recruiting for cannabis use?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for cannabis use, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cannabis use?
cannabis use research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cannabis use clinical trial?
Eligibility criteria for cannabis use trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
1
Top Sponsors
Western University, Canada 1 trial
Nova Scotia Health Authority 1 trial
Wayne State University 1 trial
Vanderbilt University Medical Center 1 trial
Elazığ Mental Health and Diseases Hospital 1 trial

Recruiting Clinical Trials

NCT03909477
Recruiting
Longitudinal Study of Xenon-129 MRI Imaging Effects of Cannabis Smoking
Enrollment
200 pts
Location
Canada
Sponsor
Western University, Canada
View Trial →
NCT03601026
Recruiting
Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use
Enrollment
120 pts
Location
Canada
Sponsor
Nova Scotia Health Authority
View Trial →
NCT06381180 Phase 1, Phase 2
Recruiting
Warrior CARE: Cannabis Behavioral Health
Enrollment
500 pts
Location
United States
Sponsor
Wayne State University
View Trial →
NCT07196462
Recruiting
Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
Enrollment
100 pts
Location
United States
Sponsor
Vanderbilt University Medical ...
View Trial →
NCT07459270
Recruiting
Psychiatric Symptom Characteristics in Methamphetamine-Induced Psychosis With and Without Lifetime Cannabis Use
Enrollment
90 pts
Location
Turkey (Türkiye)
Sponsor
Elazığ Mental Health and Disea...
View Trial →
NCT06588582
Recruiting
Perceptual Influences From Smoking Cannabis: an Experimental Study
Enrollment
166 pts
Location
United States
Sponsor
University of Colorado, Boulde...
View Trial →
NCT05119244
Recruiting
Environment and Lung Cancer
Enrollment
150 pts
Location
France
Sponsor
Centre Chirurgical Marie Lanne...
View Trial →

Related Conditions

schizophrenia (2) psychosis (2) cannabis smoking (1) marijuana smoking (1) marijuana usage (1) mental illness (1) bipolar disorder (1) major depressive disorder (1) post traumatic stress disorder (1) suicide (1) veterans (1) marijuana (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology